surgical patient
Conditions
Interventions
Propofol Sequential Test Group:1. The intervention in this study is the dosage regimen of intravenous Propofol Emulsion Injection (manufacturer: Xi'an Libang Pharmaceutical Co., Ltd.). All doses are a
Sponsors
People's Hospital of Changdu City, Xizang
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients scheduled for endotracheal intubation under general anesthesia, regardless of gender, aged 18 to 65 years, with BMI between 18 and 28 kg/m², ASA (American Society of Anesthesiologists) Class I or II, Mallampati Class I or II, normal mouth opening, and normal head and neck movement.
Exclusion criteria
Exclusion criteria: Difficult airway or potentially difficult airway, uncontrolled or poorly controlled systemic diseases (such as hypertension, diabetes), pregnancy, alcoholism, allergy to study drugs, history of illegal drug use, neurological diseases, or inability to communicate effectively. In addition, initial tracheal intubation failure, occurrence of emergencies during induction, and use of vasoactive drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MOAA/S Assessment Scale;blood pressure;heart rate; | — |
Countries
China
Contacts
Public ContactLi Shuiying
People's Hospital of Changdu City, Tibet
Outcome results
None listed